Home > Insider Trading > Filing (0000899243-21-004788)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1787400	Nkarta Inc.	NKTX	Pharmaceutical Preparations (2834)	474515206

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1816549	James Trager	C/O Nkarta, Inc. 6000 Shoreline Court, Suite 102 South San Francisco CA 94080	Chief Scientific Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-02-01	2,250	$3.89	50,672	No	4	M	Direct
Common Stock	Disposition	2021-02-01	2,034	$38.07	48,638	No	4	S	Direct
Common Stock	Disposition	2021-02-01	1,566	$39.46	47,072	No	4	S	Direct
Common Stock	Acquisiton	2021-02-02	2,800	$18.00	49,872	No	4	M	Direct
Common Stock	Disposition	2021-02-02	2,800	$40.00	47,072	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2021-02-01	2,250	$0.00	2,250	$3.89
Common Stock	Stock Option (right to buy)	Disposition	2021-02-02	2,800	$0.00	2,800	$18.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
59,912		2029-09-05	No	4	M	Direct
79,600		2030-07-08	No	4	M	Direct

Footnotes

The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date.
This transaction was executed in multiple trades at prices ranging from $37.71 to $38.52. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $39.00 to $39.65. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This option originally covered 62,162 shares of NKTX common stock and was scheduled to vest and become exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following September 5, 2019.
This option originally covered 82,400 shares of NKTX common stock and was scheduled to vest and become exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following July 9, 2020.